1 Division of Clinical Epidemiology, McGill University, Montreal, Quebec, Canada.
2 Center for Outcomes Research and Evaluation, McGill University Health Centre, Montreal, Quebec, Canada.
Clin Rehabil. 2017 Sep;31(9):1238-1248. doi: 10.1177/0269215517692129. Epub 2017 Feb 1.
Pilot studies are meritorious for determining the feasibility of a definitive clinical trial in terms of conduct and potential for efficacy, but their possible applications for planning a future trial are not always fully realized. The purpose of this review was to estimate the extent to which pilot/feasibility studies: (i) addressed needed objectives; (ii) led to definitive trials; and (iii) whether the subsequent undertaking of a definitive trial was influenced by the strength of the evidence of outcome improvement.
Trials published in the journal Clinical Rehabilitation, since its inception, were eligible if the word 'pilot' or 'feasibility' was specified somewhere in the article. A total of 191 studies were reviewed, results were summarized descriptively, and between-group effect sizes were computed.
The specific purposes of piloting were stated in only 58% ( n = 110) of the studies. The most frequent purpose was to estimate the potential for efficacy (85%), followed by testing the feasibility of the intervention (60%). Only 12% of the studies were followed by a definitive trial; <4% of studies had a main study underway or a published study protocol. There was no relationship between observed effect size and follow-up of pilot studies, although the confidence intervals were very wide owing to small number of trials that followed on.
Labelling and reporting of pilot studies needs to be improved to be concordant with the recently issued CONSORT guidelines. Feasibility needs to be fully tested and demonstrated prior to committing considerable human and monetary resources.
初步研究在实施和疗效潜力方面确定确证性临床试验的可行性方面是有价值的,但它们在规划未来试验方面的可能应用并不总是得到充分认识。本研究的目的是评估初步/可行性研究在多大程度上:(i)解决了必要的目标;(ii)导致确证性试验;以及(iii)试验结果改善的证据强度是否影响了确证性试验的进行。
自临床康复杂志创刊以来,只要文章中某处提到“初步”或“可行性”,该试验即符合入选条件。共审查了 191 项研究,结果进行了描述性总结,并计算了组间效应大小。
只有 58%(n=110)的研究明确说明了试验的具体目的。最常见的目的是评估疗效的潜力(85%),其次是检验干预措施的可行性(60%)。只有 12%的研究随后进行了确证性试验;<4%的研究有主要研究正在进行或有已发表的研究方案。观察到的效应大小与初步研究的后续行动之间没有关系,尽管由于后续试验数量较少,置信区间非常宽。
初步研究的标签和报告需要改进,以符合最近发布的 CONSORT 指南。在投入大量人力和财力之前,需要充分测试和证明可行性。